{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:28:55Z","timestamp":1790188135072,"version":"4.1.0"},"reference-count":284,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["35\/10\/2019-Nano\/BMS"],"award-info":[{"award-number":["35\/10\/2019-Nano\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/8\/2020\/NCD-III"],"award-info":[{"award-number":["5\/13\/8\/2020\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jconrel.2021.08.003","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T04:21:36Z","timestamp":1628223696000},"page":"589-611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"special_numbering":"C","title":["Advanced nanomedicine approaches applied for treatment of skin carcinoma"],"prefix":"10.1016","volume":"337","author":[{"given":"Harsimran","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kesharwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.08.003_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4155\/tde-2016-0093","article-title":"Skin cancer: symptoms, mechanistic pathways and treatment rationale for therapeutic delivery","volume":"8","author":"Goyal","year":"2017","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.11.001","article-title":"Skin cancer and new treatment perspectives: a review","volume":"357","author":"Sim\u00f5es","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0015","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.3390\/ijms140612222","article-title":"UV radiation and the skin","volume":"14","author":"D\u2019Orazio","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archdermatol.2010.19","article-title":"Incidence estimate of nonmelanoma skin cancer in the United States, 2006","volume":"146","author":"Rogers","year":"2010","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonu.2003.50000","article-title":"Epidemiology of melanoma and nonmelanoma skin cancer","volume":"19","author":"Geller","year":"2003","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2606271","article-title":"Skin cancer and its treatment: novel treatment approaches with emphasis on nanotechnology","volume":"2017","author":"Orthaber","year":"2017","journal-title":"J. Nanomater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.addr.2020.02.005","article-title":"Nanotechnology approaches in the current therapy of skin cancer","volume":"153","author":"Borgheti-Cardoso","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.plipres.2016.08.005","article-title":"Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions","volume":"64","author":"Akhtar","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1011-1344(01)00198-1","article-title":"The epidemiology of UV induced skin cancer","volume":"63","author":"Armstrong","year":"2001","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0050","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","article-title":"Ultraviolet radiation and skin cancer","volume":"49","author":"Narayanan","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature21056","article-title":"Dermatologist-level classification of skin cancer with deep neural networks","volume":"542","author":"Esteva","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0060","doi-asserted-by":"crossref","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12307-015-0171-0","article-title":"Architecture of chimeric spheroids controls drug transport","volume":"8","author":"Curran","year":"2015","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0070","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2147\/IJN.S129976","article-title":"Nanoparticle abraxane possesses impaired proliferation in A549 cells due to the underexpression of glucosamine 6-phosphate N-acetyltransferase 1 (GNPNAT1\/GNA1)","volume":"12","author":"Zhao","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0075","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-04-2291","article-title":"Comparative preclinical and clinical pharmacokinetics of a Cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in cremophor (Taxol)","volume":"11","author":"Sparreboom","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0080","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0085","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1016\/j.biomaterials.2012.06.068","article-title":"A review of nanocarriers for the delivery of small interfering RNA","volume":"33","author":"Kesharwani","year":"2012","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0090","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.drudis.2014.12.012","article-title":"Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery","volume":"20","author":"Kesharwani","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.mattod.2015.06.003","article-title":"PAMAM dendrimers as promising nanocarriers for RNAi therapeutics","volume":"18","author":"Kesharwani","year":"2015","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0100","first-page":"295","article-title":"Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison, nanomedicine nanotechnology","volume":"7","author":"Kesharwani","year":"2011","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0105","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s11095-014-1549-2","article-title":"Generation dependent safety and efficacy of folic acid conjugated dendrimer based anticancer drug formulations","volume":"32","author":"Kesharwani","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.pmatsci.2019.03.003","article-title":"Dendrimer-entrapped gold nanoparticles as promising nanocarriers for anticancer therapeutics and imaging","volume":"103","author":"Kesharwani","year":"2019","journal-title":"Prog. Mater. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","article-title":"Stimuli-responsive In situ gelling system for nose-to-brain drug delivery","volume":"327","author":"Agrawal","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01343","article-title":"Dendrimer entrapped microsponge gel of dithranol for effective topical treatment","volume":"5","author":"Tripathi","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0125","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.drudis.2020.04.013","article-title":"Theranostic application of nanoemulsions in chemotherapy","volume":"25","author":"Gorain","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.procbio.2021.07.011","article-title":"Nanocarrier mediated autophagy: an emerging trend for cancer therapy","volume":"109","author":"Singh","year":"2021","journal-title":"Process Biochem."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0135","first-page":"1","article-title":"Recent update on nano-phytopharmaceuticals in the management of diabetes","author":"Paul","year":"2021","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0140","doi-asserted-by":"crossref","first-page":"120848","DOI":"10.1016\/j.ijpharm.2021.120848","article-title":"Recent advances in nanoparticles mediated photothermal therapy induced tumor regression","author":"Kumar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0145","doi-asserted-by":"crossref","first-page":"120835","DOI":"10.1016\/j.ijpharm.2021.120835","article-title":"Kesharwani, nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer","volume":"605","author":"Chadar","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0150","doi-asserted-by":"crossref","first-page":"105890","DOI":"10.1016\/j.ejps.2021.105890","article-title":"Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer","volume":"164","author":"Dubey","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hoc.2020.08.010","article-title":"Biology of melanoma","volume":"35","author":"Ostrowski","year":"2021","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0160","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1751-1097.2007.00226.x","article-title":"The protective role of melanin against UV damage in human skin","volume":"84","author":"Brenner","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/cancers8120110","article-title":"Biology, therapy and implications of tumor exosomes in the progression of melanoma","volume":"8","author":"Isola","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0170","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/oxfordjournals.jbchem.a127360","article-title":"The reciprocal relationship between melanization and tyrosinase activity in melanosomes (melanin granules)","volume":"49","author":"Seiji","year":"1961","journal-title":"J. Biochem."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/jid.1961.42","article-title":"The melanosome: a distinctive subcellular particle of mammalian","volume":"36","author":"Seiji","year":"1961","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.addr.2017.09.016","article-title":"Targeted drug delivery to melanoma","volume":"127","author":"Liu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0185","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-018-0732-8","article-title":"The world of melanoma: epidemiologic, genetic, and anatomic differences of melanoma across the globe","volume":"20","author":"Dimitriou","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","article-title":"Epidemiology and risk factors of melanoma","volume":"100","author":"Carr","year":"2020","journal-title":"Surg. Clin. North Am."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1468-3083.2009.03353.x","article-title":"Smoking, sun exposure, number of nevi and previous neoplasias are risk factors for melanoma in older patients (60 years and over)","volume":"24","author":"Nagore","year":"2010","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0200","first-page":"612","article-title":"Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature","volume":"165","author":"Bauer","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2133.2010.10118.x","article-title":"Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis","volume":"164","author":"Schmitt","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature13298","article-title":"Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53","volume":"511","author":"Viros","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0215","first-page":"147","article-title":"Indoor tanning and melanoma risk: long-term evidence from a prospective population-based cohort study","author":"Ghiasvand","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0220","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pcmr.12459","article-title":"The genomic landscape of cutaneous melanoma","volume":"29","author":"Zhang","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0225","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/exd.13309","article-title":"Overcoming cell death resistance in skin cancer therapy: novel translational perspectives","volume":"26","author":"Feoktistova","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines6010006","article-title":"Non melanoma skin cancer pathogenesis overview","volume":"6","author":"Didona","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13555-016-0165-y","article-title":"Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches","volume":"7","author":"Apalla","year":"2017","journal-title":"Dermatol. Ther. (Heidelb)."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21155394","article-title":"Non-melanoma skin cancers: biological and clinical features","volume":"21","author":"Cives","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2018.03.060","article-title":"Basal cell carcinoma: epidemiology; pathophysiology; clinical and histological subtypes; and disease associations","volume":"80","author":"Cameron","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0250","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/DSS.0000000000000296","article-title":"Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods","volume":"41","author":"Kauvar","year":"2015","journal-title":"Dermatologic Surg."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/ijd.12553","article-title":"Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends","volume":"54","author":"Kallini","year":"2015","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0260","doi-asserted-by":"crossref","DOI":"10.5812\/ijcm.60846","article-title":"A review of cutaneous squamous cell carcinoma epidemiology, diagnosis, and management","volume":"11","author":"Kabir","year":"2018","journal-title":"Int. J. Cancer Manag."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0265","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: an epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0270","first-page":"22","article-title":"Dermoscopy, confocal microscopy and other non-invasive tools for the diagnosis of non-melanoma skin cancers and other skin conditions","volume":"97","author":"Malvehy","year":"2017","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0275","series-title":"PEGylated PAMAM Dendrimers: Enhancing Efficacy and Mitigating Toxicity for Effective Anticancer Drug and Gene Delivery Department of Pharmaceutical Sciences","author":"Luong","year":"2016"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","article-title":"Niosomes from 80s to present: the state of the art","volume":"205","author":"Marianecci","year":"2014","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0285","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.colsurfb.2014.12.041","article-title":"Nanotechnological carriers for cancer chemotherapy: the state of the art","volume":"126","author":"Estanqueiro","year":"2015","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0290","first-page":"211","article-title":"Liposome-based drug delivery systems","volume":"51","author":"Langner","year":"1999","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: Classification, preparation, and applications","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0300","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720107782151269","article-title":"Liposomal drug delivery systems: an update review","volume":"4","author":"Samad","year":"2007","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0305","doi-asserted-by":"crossref","first-page":"101549","DOI":"10.1016\/j.jddst.2020.101549","article-title":"Advances in liposomal drug delivery to cancer: an overview","volume":"56","author":"Saraf","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23040907","article-title":"Liposomal drug delivery systems and anticancer drugs","volume":"23","author":"Olusanya","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0315","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3923\/tasr.2012.620.635","article-title":"620-635.Pdf","author":"Vyas","year":"2012","journal-title":"Trends Appl. Sci. Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0320","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","article-title":"Composition design and medical application of liposomes","volume":"164","author":"Li","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0325","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/CAD.0b013e328346c7d6","article-title":"Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis","volume":"22","author":"Alvi","year":"2011","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0330","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.bbamem.2016.02.025","article-title":"Rational design of liposomal drug delivery systems, a review: combined experimental and computational studies of lipid membranes, liposomes and their PEGylation","volume":"1858","author":"Bunker","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0335","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/med.21404","article-title":"Metastatic melanoma: insights into the evolution of the treatments and future challenges","volume":"37","author":"Millet","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0340","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/08982104.2019.1604746","article-title":"Intracellular uptake of EGCG-loaded deformable controlled release liposomes for skin cancer","volume":"30","author":"Marwah","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0345","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2016.09.014","article-title":"Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory\/oxidative response associated with skin cancer","volume":"513","author":"Caddeo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0350","series-title":"Co-Delivery of Curcumin and STAT3 siRNA Using Deformable Cationic Liposomes to Treat Skin Cancer","author":"Jose","year":"2017"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0355","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijpharm.2019.05.002","article-title":"Nanoformulation for potential topical delivery of Vismodegib in skin cancer treatment","volume":"565","author":"Calienni","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJN.S124701","article-title":"Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells","volume":"13","author":"Singh","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/polym11091515","article-title":"Aptamer-functionalized liposomes as a potential treatment for basal cell carcinoma","volume":"11","author":"Cadinoiu","year":"2019","journal-title":"Polymers (Basel)."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0370","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.molpharmaceut.8b00047","article-title":"Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model","volume":"15","author":"Safwat","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0375","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijbiomac.2017.11.163","article-title":"NIR triggered liposome gold nanoparticles entrapping curcumin as in situ adjuvant for photothermal treatment of skin cancer","volume":"110","author":"Singh","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0380","doi-asserted-by":"crossref","first-page":"101147","DOI":"10.1016\/j.jddst.2019.101147","article-title":"Gold nanoparticles assisted co-delivery of nisin and doxorubicin against murine skin cancer","volume":"53","author":"Preet","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0385","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.apt.2017.02.003","article-title":"Vitis vinifera peel polyphenols stabilized gold nanoparticles induce cytotoxicity and apoptotic cell death in A431 skin cancer cell lines","volume":"28","author":"Nirmala","year":"2017","journal-title":"Adv. Powder Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0390","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1080\/21691401.2019.1647224","article-title":"Biologically synthesized green gold nanoparticles from Siberian ginseng induce growth-inhibitory effect on melanoma cells (B16)","volume":"47","author":"Wu","year":"2019","journal-title":"Artif. Cells, Nanomedicine Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0395","doi-asserted-by":"crossref","DOI":"10.1021\/mp5007163","article-title":"Layer-by-layer polymer coated gold nanoparticles for topical delivery of imatinib mesylate to treat melanoma","author":"Labala","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0400","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijpharm.2019.01.067","article-title":"Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice","volume":"560","author":"Moolakkadath","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0405","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08982104.2018.1556292","article-title":"Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: in vitro evaluation","volume":"29","author":"Peram","year":"2019","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0410","doi-asserted-by":"crossref","first-page":"101556","DOI":"10.1016\/j.jddst.2020.101556","article-title":"Control of basal cell carcinoma via positively charged ethosomes of Vismodegib: in vitro and in vivo studies","volume":"56","author":"Amr Gamal","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0415","doi-asserted-by":"crossref","first-page":"119278","DOI":"10.1016\/j.ijpharm.2020.119278","article-title":"Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma","volume":"581","author":"Lin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejpb.2012.02.008","article-title":"Paclitaxel-loaded ethosomes\u00ae: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses","volume":"81","author":"Paolino","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0425","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1080\/10717544.2016.1194498","article-title":"5-fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment","volume":"23","author":"Khallaf","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0430","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/02652048.2016.1200150","article-title":"Dermal delivery of doxorubicin-loaded solid lipid nanoparticles for the treatment of skin cancer","volume":"33","author":"Tupal","year":"2016","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020255","article-title":"Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies","volume":"19","author":"Clemente","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0440","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.colsurfb.2018.04.031","article-title":"Repurposing itraconazole to the benefit of skin cancer treatment: a combined azole-DDAB nanoencapsulation strategy","volume":"167","author":"Carbone","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0445","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/1061186X.2014.965717","article-title":"Sesamol-loaded solid lipid nanoparticles for treatment of skin cancer","volume":"23","author":"Geetha","year":"2015","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0450","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7150\/thno.10804","article-title":"Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells","volume":"5","author":"Shen","year":"2015","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0455","doi-asserted-by":"crossref","first-page":"111533","DOI":"10.1016\/j.jphotobiol.2019.111533","article-title":"Verteporfin-loaded mesoporous silica nanoparticles inhibit mouse melanoma proliferation in vitro and in vivo","volume":"197","author":"Clemente","year":"2019","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0460","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1039\/c3nr02787b","article-title":"Hyaluronan degrading silica nanoparticles for skin cancer therapy","volume":"5","author":"Scodeller","year":"2013","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0465","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1021\/acsami.7b05278","article-title":"Dacarbazine-loaded hollow mesoporous silica nanoparticles grafted with folic acid for enhancing Antimetastatic melanoma response","volume":"9","author":"Liu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ma14061382","article-title":"Encapsulation and enhanced release of resveratrol from mesoporous silica nanoparticles for melanoma therapy","volume":"14","author":"Marinheiro","year":"2021","journal-title":"Materials (Basel)."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0475","doi-asserted-by":"crossref","first-page":"101276","DOI":"10.1016\/j.mtcomm.2020.101276","article-title":"Efficacy of biopolymeric PVA-AuNPs and PCL-Curcumin loaded electrospun nanofibers and their anticancer activity against A431 skin cancer cell line","volume":"25","author":"Balashanmugam","year":"2020","journal-title":"Mater. Today Commun."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0985","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.eurpolymj.2019.08.001","article-title":"PEO-chitosan nanofibers containing carboxymethyl-hexanoyl chitosan\/dodecyl sulfate nanoparticles loaded with pyrazoline for skin cancer treatment","volume":"119","author":"Rengifo","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0485","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.carbpol.2017.02.067","article-title":"Preparation and characterization of metformin surface modified cellulose nanofiber gel and evaluation of its anti-metastatic potentials","volume":"165","author":"Nurani","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0480","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jphotobiol.2017.08.032","article-title":"Preparation and characterization of Fe3O4-Ag2O quantum dots decorated cellulose nanofibers as a carrier of anticancer drugs for skin cancer","volume":"175","author":"Fakhri","year":"2017","journal-title":"J. Photochem. Photobiol. B Biol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0490","doi-asserted-by":"crossref","first-page":"105002","DOI":"10.1016\/j.ejps.2019.105002","article-title":"A novel core-shell nanofiber drug delivery system intended for the synergistic treatment of melanoma","volume":"137","author":"Zhu","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0495","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7150\/thno.29026","article-title":"Low molecular weight heparin-coated and dendrimer-based core-shell nanoplatform with enhanced immune activation and multiple anti-metastatic effects for melanoma treatment","volume":"9","author":"Xia","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0500","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1080\/21691401.2016.1247850","article-title":"Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation","volume":"45","author":"Jangdey","year":"2017","journal-title":"Artif. Cells, Nanomedicine Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0505","doi-asserted-by":"crossref","first-page":"119705","DOI":"10.1016\/j.ijpharm.2020.119705","article-title":"Topical nanostructured lipid carrier gel of quercetin and resveratrol: formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer","volume":"587","author":"Imran","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0510","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jbiotec.2013.01.003","article-title":"Skin cancer treatment by albumin\/5-Fu loaded magnetic nanocomposite spheres in a mouse model","volume":"164","author":"Misak","year":"2013","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0515","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jddst.2018.08.004","article-title":"Green synthesis of silver nanoparticles using Trapa natans extract and their anticancer activity against A431 human skin cancer cells","volume":"47","author":"Saber","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0520","doi-asserted-by":"crossref","first-page":"18243","DOI":"10.1021\/jp063879z","article-title":"Plasmon coupling in nanorod assemblies: optical absorption, discrete dipole approximation simulation, and exciton-coupling model","volume":"110","author":"Jain","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/app10113824","article-title":"Gold nanoparticles for drug delivery and cancer therapy","volume":"10","author":"Siddique","year":"2020","journal-title":"Appl. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071979","article-title":"Gold nanoparticles in diagnostics and therapeutics for human cancer","volume":"19","author":"Singh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0535","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1259\/bjr\/59448833","article-title":"Gold nanoparticles as novel agents for cancer therapy","volume":"85","author":"Jain","year":"2012","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0540","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005872","article-title":"Cancer nanomedicine: from drug delivery to imaging","volume":"5","author":"Chow","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/nano9070920","article-title":"Contrast enhancement for portal imaging in nanoparticle-enhanced radiotherapy: a monte carlo phantom evaluation using flattening-filter-free photon beams","volume":"9","author":"Abdulle","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0550","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1039\/C1NR11188D","article-title":"Gold nanoparticles: preparation, properties, and applications in bionanotechnology","volume":"4","author":"Yeh","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0555","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/ja908117a","article-title":"Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin","volume":"132","author":"Brown","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0560","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jgeb.2016.05.007","article-title":"Anticancer activity of eco-friendly gold nanoparticles against lung and liver cancer cells","volume":"14","author":"Rajeshkumar","year":"2016","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0565","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7150\/thno.10657","article-title":"Off to the organelles - killing cancer cells with targeted gold nanoparticles","volume":"5","author":"Kodiha","year":"2015","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0570","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijpharm.2015.02.038","article-title":"Current trends in using polymer coated gold nanoparticles for cancer therapy","volume":"484","author":"Muddineti","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0575","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jphp.12017","article-title":"Nanometric gold in cancer nanotechnology: current status and future prospect","volume":"65","author":"Ahmad","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0580","series-title":"US5540934A - Compositions for Applying Active Substances to or Through the Skin - Google Patents","year":"1996"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0585","series-title":"Transdermal Ethosomal Gel Nanocarriers; a Promising Strategy for Enhancement of Anti-Hypertensive Effect of Carvedilol","author":"Ibrahim","year":"2019"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0590","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0168-3659(99)00222-9","article-title":"Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties","volume":"65","author":"Touitou","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0600","doi-asserted-by":"crossref","DOI":"10.1208\/pt0804107","article-title":"Enhanced transdermal delivery of salbutamol sulfate via ethosomes","volume":"8","author":"Bendas","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0605","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.2147\/IJN.S33048","article-title":"Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations","volume":"8","author":"Romero","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0610","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0378-5173(93)90364-L","article-title":"Interaction of phospholipid liposomes with lipid model mixtures for stratum corneum lipids","volume":"99","author":"Blume","year":"1993","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.12.005","article-title":"Lipid vesicles for skin delivery of drugs: reviewing three decades of research","volume":"332","author":"Elsayed","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0620","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i1.20","article-title":"Ethosomes: new prospects in transdermal delivery","volume":"20","author":"Godin","year":"2003","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0625","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2009.11.029","article-title":"Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies","volume":"387","author":"Shumilov","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0630","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/10731199.2012.743903","article-title":"Preparation and in vitro percutaneous penetration of simvastatin ethosome gel","volume":"41","author":"An","year":"2013","journal-title":"Artif. Cells, Nanomedicine Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0635","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/17425247.2013.860130","article-title":"Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus","volume":"11","author":"Mbah","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0640","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3109\/10717544.2014.889777","article-title":"Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents","volume":"22","author":"Pandey","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0645","first-page":"100027","article-title":"Mechanism investigation of ethosomes transdermal permeation","volume":"1","author":"Niu","year":"2019","journal-title":"Int. J. Pharm. X."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0650","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0655","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0660","series-title":"SOLID LIPID NANOPARTICLES Solid Lipid Nanoparticles for the Delivery of Pharmaceutical Actives NANOPARTICLE FORMULATIONS","author":"Loxley","year":"2009"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0665","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.addr.2003.12.002","article-title":"Solid lipid nanoparticles for parenteral drug delivery","volume":"56","author":"Wissing","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0670","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.addr.2011.05.017","article-title":"Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles","volume":"63","author":"Cai","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0675","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/mp200109m","article-title":"Biomimetic solid lipid nanoparticles for oral bioavailability enhancement of low molecular weight heparin and its lipid conjugates: in vitro and in vivo evaluation","volume":"8","author":"Paliwal","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0680","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/157341308783591816","article-title":"Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology","volume":"4","author":"Vyas","year":"2008","journal-title":"Curr. Nanosci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0685","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1358\/mf.2005.27.2.876286","article-title":"Solid lipid nanoparticles as drug delivery systems","volume":"27","author":"Manjunath","year":"2005","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0690","first-page":"80","article-title":"Solid lipid nanoparticles: a review","volume":"2","author":"Ekambaram","year":"2012","journal-title":"Sci. Revs. Chem. Commun."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0695","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40199-015-0128-3","article-title":"Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants\/stabilizers on physicochemical properties of nanoparticles","volume":"23","author":"Ebrahimi","year":"2015","journal-title":"Daru."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0700","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1007\/s11095-013-1229-7","article-title":"Recent advances in lipid-based formulation technology","volume":"30","author":"Porter","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0705","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2008.06.028","article-title":"Development of SLNs from natural lipids: application to topical delivery of tretinoin","volume":"363","author":"Mandawgade","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0710","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijpharm.2012.03.032","article-title":"Solid lipid nanoparticles as intracellular drug transporters: An investigation of the uptake mechanism and pathway","volume":"430","author":"Martins","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0715","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/mnfr.201000310","article-title":"Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin","volume":"55","author":"Kakkar","year":"2011","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0720","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.carbpol.2011.01.037","article-title":"Solid lipid nanoparticles modified with chitosan oligosaccharides for the controlled release of doxorubicin","volume":"84","author":"Ying","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0725","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/1061186X.2012.702767","article-title":"Role of CD44 in tumour progression and strategies for targeting","volume":"20","author":"Negi","year":"2012","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0730","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00280-010-1462-2","article-title":"Hyaluronic acid-paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts","volume":"68","author":"De Stefano","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0735","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1002\/smll.200901789","article-title":"Mesoporous silica nanoparticles for intracellular controlled drug delivery","volume":"6","author":"Vivero-Escoto","year":"2010","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0740","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/17435889.2.1.99","article-title":"Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems","volume":"2","author":"Giri","year":"2007","journal-title":"Nanomedicine."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0745","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.biomaterials.2009.10.046","article-title":"The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses","volume":"31","author":"He","year":"2010","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0750","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/nn800072t","article-title":"Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery","volume":"2","author":"Liong","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0755","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/ar2000259","article-title":"Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications","volume":"44","author":"Lee","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0760","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/adfm.200601191","article-title":"Mesoporous silica nanoparticles for drug delivery and biosensing applications","volume":"17","author":"Slowing","year":"2007","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0765","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1039\/c1jm10803d","article-title":"Fluorescence turn-on chemodosimeter-functionalized mesoporous silica nanoparticles and their application in cell imaging","volume":"21","author":"Liu","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0770","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1039\/c3cs35359a","article-title":"Mesoporous silica films as a novel biomaterial: applications in the middle ear","volume":"42","author":"Ehlert","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0775","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1039\/C2BM00071G","article-title":"A tissue engineering approach based on the use of bioceramics for bone repair","volume":"1","author":"Salinas","year":"2013","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0780","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1016\/j.biomaterials.2008.08.009","article-title":"The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis","volume":"29","author":"Moulari","year":"2008","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0785","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/smll.201000538","article-title":"Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals","volume":"6","author":"Lu","year":"2010","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0790","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1039\/c1cs15246g","article-title":"Mesoporous silica nanoparticles in biomedical applications","volume":"41","author":"Li","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0795","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1039\/c2cs15308d","article-title":"Functionalized mesoporous silica materials for controlled drug delivery","volume":"41","author":"Yang","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0800","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1002\/anie.200604488","article-title":"Mesoporous materials for drug delivery","volume":"46","author":"Vallet-Reg\u00ed","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0805","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1007\/s12010-011-9383-z","article-title":"Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms","volume":"165","author":"Fernandez-Fernandez","year":"2011","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0810","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2174\/138945011795906624","article-title":"Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment","volume":"12","author":"Rosenholm","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0815","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/17425247.2014.953051","article-title":"Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery","volume":"12","author":"Baeza","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0820","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/cm402592t","article-title":"Multifunctional mesoporous silica nanoparticles as a universal platform for drug delivery","volume":"26","author":"Argyo","year":"2014","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1387-1811(99)00082-7","article-title":"The preparation of highly ordered MCM-41 with extremely low surfactant concentration","volume":"32","author":"Cai","year":"1999","journal-title":"Microporous Mesoporous Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0830","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0835","doi-asserted-by":"crossref","first-page":"5924","DOI":"10.1002\/anie.200600734","article-title":"The supramolecular chemistry of organic-inorganic hybrid materials","volume":"45","author":"Descalzo","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0840","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1021\/ar600032u","article-title":"Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release","volume":"40","author":"Trewyn","year":"2007","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0845","doi-asserted-by":"crossref","first-page":"14792","DOI":"10.1021\/ja0645943","article-title":"Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells","volume":"128","author":"Slowing","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0850","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1096\/fj.05-4288fje","article-title":"Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking","volume":"19","author":"Huang","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0855","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.biomaterials.2007.03.006","article-title":"The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells","volume":"28","author":"Chung","year":"2007","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0860","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12030-008-9003-3","article-title":"Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells","volume":"3","author":"Lu","year":"2007","journal-title":"Nanobiotechnology."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0865","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1021\/nn400199t","article-title":"Versatile fluorescence resonance energy transfer-based mesoporous silica nanoparticles for real-time monitoring of drug release","volume":"7","author":"Lai","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0870","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1021\/nl400681f","article-title":"Targeted drug delivery in cancer cells with red-light photoactivated mesoporous silica nanoparticles","volume":"13","author":"Mackowiak","year":"2013","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0875","doi-asserted-by":"crossref","first-page":"15261","DOI":"10.1021\/jp061691+","article-title":"Adsorption of DNA into mesoporous silica","volume":"110","author":"Solberg","year":"2006","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0880","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0885","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms1727","article-title":"Melanoma whole-exome sequencing identifies V600E B-RAF amplification-mediated acquired B-RAF inhibitor resistance","volume":"3","author":"Shi","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0890","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ccr.2010.11.023","article-title":"Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R\/PI3K","volume":"18","author":"Villanueva","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0895","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti\u2013PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0900","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"7","author":"Koyama","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0905","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejps.2017.07.001","article-title":"Electrospun polymeric nanofibers: new horizons in drug delivery","volume":"107","author":"Thakkar","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0910","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17434440.2014.953058","article-title":"Polymer-based platforms by electric field-assisted techniques for tissue engineering and cancer therapy","volume":"12","author":"Guarino","year":"2014","journal-title":"Expert Rev. Med. Devices."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0915","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/ten.teb.2011.0390","article-title":"Fabrication of large pores in electrospun nanofibrous scaffolds for cellular infiltration: a review","volume":"18","author":"Zhong","year":"2012","journal-title":"Tissue Eng. - Part B Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0920","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0142-9612(98)00099-4","article-title":"Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration","volume":"19","author":"Widmer","year":"1998","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0925","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1089\/ten.2005.11.1149","article-title":"Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell orientation","author":"Ma","year":"2005","journal-title":"Tissue Eng."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0930","series-title":"Formation of Silicalite-1 Hollow Spheres by the Self-Assembly of Nanocrystals","author":"Naik","year":"2003"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0935","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0142-9612(03)00536-2","article-title":"Gravity spinning of polycaprolactone fibres for applications in tissue engineering","volume":"25","author":"Williamson","year":"2004","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0940","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jddst.2017.07.003","article-title":"Nanofiber based drug delivery systems for skin: a promising therapeutic approach","volume":"41","author":"Kamble","year":"2017","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0945","article-title":"Nanofibers offer alternative ways to the treatment of skin infections","volume":"2010","author":"Dicks","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0950","series-title":"Org. Mater. as Smart Nanocarriers Drug Deliv.","first-page":"147","article-title":"Polymeric nanofibers for controlled drug delivery applications","author":"Patel","year":"2018"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0955","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2015.02.043","article-title":"Critical attributes of nanofibers: preparation, drug loading, and tissue regeneration","volume":"484","author":"Pelipenko","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0960","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.2174\/138161208785740180","article-title":"Nanotechnology for nanomedicine and delivery of drugs","volume":"14","author":"Venugopal","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0965","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10118-014-1491-0","article-title":"Prevention of local liver cancer recurrence after surgery using multilayered cisplatin-loaded polylactide electrospun nanofibers","volume":"32","author":"Zhang","year":"2014","journal-title":"Chinese J. Polym. Sci. (English Ed.)"},{"key":"10.1016\/j.jconrel.2021.08.003_bb0970","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.biomaterials.2008.01.011","article-title":"Electrospinning: applications in drug delivery and tissue engineering","volume":"29","author":"Sill","year":"2008","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0975","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.biotechadv.2010.01.004","article-title":"Electrospinning: a fascinating fiber fabrication technique","volume":"28","author":"Bhardwaj","year":"2010","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0980","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701024","article-title":"Emerging Roles of Electrospun Nanofibers in Cancer Research","volume":"7","author":"Chen","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0990","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jddst.2015.04.006","article-title":"Generation dependent hemolytic profile of folate engineered poly(propyleneimine) dendrimer","volume":"28","author":"Kesharwani","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb0995","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"1","article-title":"History and introduction of dendrimers","author":"Choudhury","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1000","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3390\/molecules22091401","article-title":"Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy","volume":"22","author":"Palmerston Mendes","year":"2017","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1005","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1010","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/AAC.50.5.1696-1700.2006","article-title":"Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model","volume":"50","author":"Patton","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1015","first-page":"1","article-title":"Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics","author":"Singh","year":"2021","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1020","doi-asserted-by":"crossref","first-page":"111837","DOI":"10.1016\/j.colsurfb.2021.111837","article-title":"PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy","volume":"204","author":"Surekha","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.progpolymsci.2005.01.007","article-title":"Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry","volume":"30","author":"Tomalia","year":"2005","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.progpolymsci.2008.08.003","article-title":"Bioinspired application of dendrimers: from bio-mimicry to biomedical applications","volume":"34","author":"Jang","year":"2009","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1035","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.micron.2007.06.009","article-title":"The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy","volume":"38","author":"Khosravi-Darani","year":"2007","journal-title":"Micron."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1040","series-title":"Nanocarrier Technol. Front. Nanotherapy","first-page":"207","article-title":"Interaction of dendrimers with model lipid membranes assessed by DSC and raman spectroscopy","author":"Gardikis","year":"2006"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A new class of polymers: starburst-dendritic macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polym. J."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1050","doi-asserted-by":"crossref","first-page":"7638","DOI":"10.1021\/ja00177a027","article-title":"Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules","volume":"112","author":"Hawker","year":"1990","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1055","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"75","article-title":"Dendrimer nomenclature and synthesis methods","author":"Gawande","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1065","first-page":"705","article-title":"Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers, nanomedicine nanotechnology","volume":"11","author":"Jain","year":"2015","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1070","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.04213-14","article-title":"Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: formulation development and in vitro and in vivo evaluation","author":"Jain","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1075","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"95","article-title":"Types of dendrimers","author":"Jain","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1080","doi-asserted-by":"crossref","DOI":"10.1016\/S1461-5347(99)00203-5","article-title":"Designing dendrimers for drug delivery","author":"Liu","year":"1999","journal-title":"Pharm. Sci. Technol. Today."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2012.09.030","article-title":"Dendrimers in biomedical applications-reflections on the field","volume":"64","author":"Svenson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1090","doi-asserted-by":"crossref","DOI":"10.1038\/nbt1171","article-title":"Designing dendrimers for biological applications","author":"Lee","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1095","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"125","article-title":"Characterization of dendrimers","author":"Kokare","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1100","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.addr.2005.09.012","article-title":"Dendrimer-drug interactions","volume":"57","author":"D\u2019Emanuele","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1105","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1021\/bm050802s","article-title":"Dendrimers: novel polymeric nanoarchitectures for solubility enhancement","volume":"7","author":"Gupta","year":"2006","journal-title":"Biomacromolecules."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1039\/b309043b","article-title":"Dendrimers in drug research","volume":"33","author":"Boas","year":"2004","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1115","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"449","article-title":"Conclusion and future considerations of dendrimers","author":"Singh","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1120","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"63","article-title":"Biological interaction of dendrimers","author":"Bandaru","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1125","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"273","article-title":"Dendrimer for solubility enhancement","author":"Gorain","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1130","series-title":"Dendrimer-Based Nanotherapeutics","first-page":"143","article-title":"Safety and toxicity issues of dendrimers","author":"Kumbhar","year":"2021"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1135","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1021\/cr0103874","article-title":"Dendrimers as support for recoverable catalysts and reagents","volume":"102","author":"Van Heerbeek","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1140","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1021\/cr010323t","article-title":"Dendritic catalysts and dendrimers in catalysis","volume":"101","author":"Astruc","year":"2001","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1145","series-title":"Pharm. Appl. Dendrimers","first-page":"131","article-title":"Dendrimers for anticancer drug delivery","author":"Tripathi","year":"2020"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1150","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11060294","article-title":"Nanoparticle- and nanoporous-membrane-mediated delivery of therapeutics","volume":"11","author":"Mabrouk","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1155","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4155\/tde.10.13","article-title":"Nanoparticle-assisted combination therapies for effective cancer treatment","volume":"1","author":"Hu","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bios.2014.10.081","article-title":"Highly sensitive dendrimer-based nanoplasmonic biosensor for drug allergy diagnosis","volume":"66","author":"Soler","year":"2015","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5173(99)00463-9","article-title":"Polyamidoamine Starburst\u00ae dendrimers as solubility enhancers","volume":"197","author":"Milhem","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1170","doi-asserted-by":"crossref","DOI":"10.1016\/S1367-5931(02)00347-2","article-title":"Dendritic polymer macromolecular carriers for drug delivery","author":"Patri","year":"2002","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1175","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2741\/2774","article-title":"Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery","volume":"13","author":"Cheng","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejmech.2006.07.015","article-title":"Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug","volume":"42","author":"Ma","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1185","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.ejmech.2006.12.035","article-title":"Polyamidoamine (PAMAM) dendrimers as biocompatible carriers of quinolone antimicrobials: An in vitro study","volume":"42","author":"Cheng","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1190","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3109\/21691401.2015.1129625","article-title":"Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers","volume":"44","author":"Singh","year":"2016","journal-title":"Artif. Cells, Nanomedicine Biotechnol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1195","doi-asserted-by":"crossref","first-page":"1325708","DOI":"10.1080\/20022727.2017.1325708","article-title":"Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art","volume":"8","author":"Rai","year":"2017","journal-title":"Nano Rev. Exp."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0005-2736(01)00369-8","article-title":"New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes","volume":"1514","author":"Cevc","year":"2001","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1205","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/S0142-9612(00)00063-6","article-title":"Carriers for skin delivery of trihexyphenidyl HCl: Ethosomes vs. liposomes","volume":"21","author":"Dayan","year":"2000","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1210","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s002680010201","article-title":"New ultradeformable drug carriers for potential transdermal application of interleukin-2 and interferon-\u03b1: theoretic and practical aspects","volume":"24","author":"Hofer","year":"2000","journal-title":"World J. Surg."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1215","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijpharm.2008.04.033","article-title":"Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium","volume":"360","author":"Manosroi","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ijpharm.2012.07.003","article-title":"Preparation and quality assessment of itraconazole transfersomes","volume":"436","author":"Zheng","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbamem.2004.01.006","article-title":"Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage","volume":"1663","author":"Cevc","year":"2004","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1230","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.addr.2003.10.028","article-title":"Lipid vesicles and other colloids as drug carriers on the skin","volume":"56","author":"Cevc","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1235","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0005-2736(03)00172-X","article-title":"Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes\u00ae","volume":"1614","author":"Cevc","year":"2003","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0264-410X(97)00185-0","article-title":"Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes","volume":"16","author":"Paul","year":"1998","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1245","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0005-2736(92)90154-E","article-title":"Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force","volume":"1104","author":"Cevc","year":"1992","journal-title":"BBA - Biomembr."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1250","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.colsurfb.2011.12.004","article-title":"A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro\/in vivo evaluation","volume":"92","author":"Song","year":"2012","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1255","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.xphs.2016.10.001","article-title":"Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application","volume":"106","author":"Jain","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1260","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"El Zaafarany","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1265","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1081\/DDC-120025458","article-title":"Transfersomes - a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation","volume":"29","author":"Jain","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1270","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1213\/00000539-199210000-00027","article-title":"Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes","volume":"75","author":"Planas","year":"1992","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1467-2494.2005.00264.x","article-title":"Elastic vesicles as topical\/transdermal drug delivery systems","volume":"27","author":"Choi","year":"2005","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1280","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijpharm.2007.03.006","article-title":"Cationic transfersomes based topical genetic vaccine against hepatitis B","volume":"340","author":"Mahor","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1285","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijpharm.2006.05.027","article-title":"Deformable liposomes and ethosomes: mechanism of enhanced skin delivery","volume":"322","author":"Elsayed","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1290","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1211\/0022357011776450","article-title":"Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro","volume":"53","author":"El Maghraby","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1295","series-title":"Modif. Drug Deliv. Technol.","first-page":"557","article-title":"Transfersomes: innovative transdermal drug carriers","year":"2020"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1300","series-title":"Transfersomes: A Surrogated Carrier for Transdermal Drug Delivery System | Request PDF","year":"2011"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1305","series-title":"Approaches for Improving the Pharmacological and Pharmacokinetics Properties of Herbal Drugs, Undefined","author":"Mathur","year":"2013"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1310","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-3659(00)00358-8","article-title":"In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density","volume":"71","author":"Zauner","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1315","series-title":"Nano-lipid Carriers for Topical Application: Current Scenario","author":"Purohit","year":"2016"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1320","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.aca.2012.07.010","article-title":"An overview of the analytical characterization of nanostructured drug delivery systems: towards green and sustainable pharmaceuticals: a review","volume":"744","author":"Domingo","year":"2012","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1325","first-page":"143","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics, Nanomedicine nanotechnology","volume":"12","author":"Beloqui","year":"2016","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1330","first-page":"30","article-title":"Lipid nanoparticles: a modern formulation approach in topical drug delivery systems","volume":"1","author":"Hajare","year":"2014","journal-title":"J. Adv. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1335","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ptr.5239","article-title":"Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1","volume":"29","author":"El-Bahr","year":"2015","journal-title":"Phyther. Res."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1340","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-019-1337-8","article-title":"Potential of lipid nanoparticles (SLNs and NLCs) in enhancing oral bioavailability of drugs with poor intestinal permeability","volume":"20","author":"Talegaonkar","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1345","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.materresbull.2007.06.030","article-title":"Ultrafine magnetic particles dispersed in silica: characterization of cobalt iron citrate precursor and magnetic properties","volume":"43","author":"Montemayor","year":"2008","journal-title":"Mater. Res. Bull."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1350","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.physe.2010.01.042","article-title":"Preparation and characterization of silica-coated iron-oxide bionanoparticles under N2 gas","volume":"42","author":"Khosroshahi","year":"2010","journal-title":"Phys. E Low-Dimensional Syst. Nanostructures."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1355","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.addr.2006.09.007","article-title":"Mathematical modeling and simulation of drug release from microspheres: implications to drug delivery systems","volume":"58","author":"Arifin","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1360","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1021\/ja061393q","article-title":"Mesoporous silica-magnetite nanocomposite: Fabrication and applications in magnetic bioseparations","volume":"128","author":"Sen","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1365","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/smll.200700456","article-title":"Simple synthesis of functionalized superparamagnetic magnetite\/silica core\/shell nanoparticles and their application as magnetically separable high-performance biocatalysts","volume":"4","author":"Lee","year":"2008","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1370","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/adfm.200801681","article-title":"Supercritical-fluid-assisted one-pot synthesis of biocompatible core(\u03b3-Fe2O3)\/shell(SiO2) nanoparticles as high relaxivity T2-contrast agents for magnetic resonance imaging","volume":"19","author":"Taboada","year":"2009","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1375","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.mseb.2010.12.012","article-title":"Highly selective and sensitive magnetic silica nanoparticles based fluorescent sensor for detection of Zn2+ ions","volume":"176","author":"Liu","year":"2011","journal-title":"Mater. Sci. Eng. B Solid-State Mater. Adv. Technol."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1380","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/la701570z","article-title":"Magnetic-sensitive silica nanospheres for controlled drug release","volume":"24","author":"Hu","year":"2008","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1385","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jccs.201700067","article-title":"A review of silver nanoparticles: research trends, global consumption, synthesis, properties, and future challenges","volume":"64","author":"Syafiuddin","year":"2017","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1390","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nmat2099","article-title":"Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil","volume":"7","author":"Kumar","year":"2008","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1395","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature12523","article-title":"Ultrastable silver nanoparticles","volume":"501","author":"Desireddy","year":"2013","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1400","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1126\/science.1077229","article-title":"Shape-controlled synthesis of gold and silver nanoparticles","volume":"298","author":"Sun","year":"2002","journal-title":"Science (80-.)"},{"key":"10.1016\/j.jconrel.2021.08.003_bb1405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nmat2629","article-title":"Plasmonics for improved photovoltaic devices","volume":"9","author":"Atwater","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1410","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1021\/cr100275d","article-title":"Controlling the synthesis and assembly of silver nanostructures for plasmonic applications","volume":"111","author":"Rycenga","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1415","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.saa.2014.10.003","article-title":"Intracellular synthesis of silver nanoparticle by actinobacteria and its antimicrobial activity","volume":"136","author":"Otari","year":"2015","journal-title":"Spectrochim. Acta - Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1420","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2228-5326-2-32","article-title":"Silver nanoparticles: mechanism of antimicrobial action, synthesis, medical applications, and toxicity effects","volume":"2","author":"Prabhu","year":"2012","journal-title":"Int. Nano Lett."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1425","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1021\/la2042058","article-title":"Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types","volume":"28","author":"Suresh","year":"2012","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2021.08.003_bb1430","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jlumin.2018.03.075","article-title":"Enhanced chemiluminescence by au-ag core-shell nanoparticles: a general and practical biosensing platform for tumor marker detection","volume":"201","author":"Zhang","year":"2018","journal-title":"J. Lumin."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921004028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921004028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T18:56:38Z","timestamp":1772736998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921004028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":284,"alternative-id":["S0168365921004028"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.003","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced nanomedicine approaches applied for treatment of skin carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}